Vgkc is dead: long live lgi1- and caspr2-antibodies. intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
Asıl Yazarlar: | Lang, B, Maddison, P, Dettmann, I, Adcock, J, Buckley, C, Leite, I, Vincent, A, Komorowski, L, Waters, P, Irani, S |
---|---|
Materyal Türü: | Conference item |
Dil: | English |
Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2017
|
Benzer Materyaller
-
Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
Yazar:: Michael, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020) -
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
Yazar:: Lang, B, ve diğerleri
Baskı/Yayın Bilgisi: (2017) -
LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
Yazar:: Binks, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017) -
Distinct HLA associations of LGI1 and CASPR2-antibody diseases
Yazar:: Binks, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018) -
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies: Evidence for relative pathogenicity
Yazar:: Lang, B, ve diğerleri
Baskı/Yayın Bilgisi: (2017)